CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure S Batkai, C Genschel, J Viereck, S Rump, C Bär, T Borchert, D Traxler, ... European heart journal 42 (2), 192-201, 2021 | 117 | 2021 |
Chronic rupture of the left ventricular wall with a giant pseudoaneurysm M Riesenhuber, M Schneider, A Maier, M Rohla, M Gyöngyösi European Heart Journal-Cardiovascular Imaging 20 (2), 242-242, 2019 | 1 | 2019 |
Clinical cell-based cardiac regeneration therapy in patients with ischemic heart failure= Klinikai sejtalapú kardiális regenerációs kezelés az iszkémiás szívelégtelenségben … M Gyöngyösi, N Nyolczas, C Müller, K Zlabinger, L Mandic, ... Cardiologia Hungarica 48 (2), 111-117, 2018 | | 2018 |
Effect of ischemic preconditioning and postconditioning on exosome-rich fraction microRNA levels, in relation with electrophysiological parameters and ventricular arrhythmia in … A Spannbauer, D Traxler, D Lukovic, K Zlabinger, J Winkler, A Gugerell, ... International journal of molecular sciences 20 (9), 2140, 2019 | 40 | 2019 |
Filamentous fungal infections in a tertiary care setting: epidemiology and clinical outcome M Van den Nest, G Wagner, M Riesenhuber, C Dolle, E Presterl, ... Journal of Fungi 7 (1), 40, 2021 | 5 | 2021 |
Heart failure with reduced ejection fraction is characterized by systemic NEP downregulation IJ Pavo, N Pavo, N Kastner, D Traxler, D Lukovic, K Zlabinger, ... Basic to Translational Science 5 (7), 715-726, 2020 | 16 | 2020 |
Invasive Fungal Infection Caused by Exophiala dermatitidis in a Patient After Lung Transplantation: Case Report and Literature Review R Klasinc, M Riesenhuber, A Bacher, B Willinger Mycopathologia 184, 107-113, 2019 | 19 | 2019 |
Large animal models of cell-free cardiac regeneration A Spannbauer, J Mester-Tonczar, D Traxler, N Kastner, K Zlabinger, ... Biomolecules 10 (10), 1392, 2020 | 20 | 2020 |
Large animal models of heart failure with reduced ejection fraction (HFrEF) A Spannbauer, D Traxler, K Zlabinger, A Gugerell, J Winkler, ... Frontiers in cardiovascular medicine 6, 117, 2019 | 66 | 2019 |
Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance M Gyöngyösi, D Lukovic, K Zlabinger, A Spannbauer, A Gugerell, N Pavo, ... Cardiovascular research 116 (5), 970-982, 2020 | 69 | 2020 |
Preclinical development of a miR-132 inhibitor for heart failure treatment A Foinquinos, S Batkai, C Genschel, J Viereck, S Rump, M Gyöngyösi, ... Nature communications 11 (1), 633, 2020 | 164 | 2020 |
Quantitative hybrid cardiac [18F] FDG-PET-MRI images for assessment of cardiac repair by preconditioned cardiosphere-derived cells J Winkler, D Lukovic, J Mester-Tonczar, K Zlabinger, A Gugerell, N Pavo, ... Molecular Therapy Methods & Clinical Development 18, 354-366, 2020 | 14 | 2020 |
Sex differences and long-term outcome in patients with pacemakers M Riesenhuber, A Spannbauer, F Rauscha, H Schmidinger, A Boszotta, ... Frontiers in Cardiovascular Medicine 7, 569060, 2020 | 13 | 2020 |
The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: an open-label, controlled … S Weisshaar, B Litschauer, S Bucher, M Riesenhuber, S Kapiotis, ... Medicine 95 (27), e4145, 2016 | 2 | 2016 |
Transcriptional alterations by ischaemic postconditioning in a pig infarction model: Impact on microvascular protection D Lukovic, A Gugerell, K Zlabinger, J Winkler, N Pavo, T Baranyai, ... International Journal of Molecular Sciences 20 (2), 344, 2019 | 16 | 2019 |